These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32488137)

  • 1. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters.
    Park JW; Chang HJ; Yeo HY; Han N; Kim BC; Kong SY; Kim J; Oh JH
    Br J Cancer; 2020 Aug; 123(4):610-618. PubMed ID: 32488137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Neurotransmitters (Dopamine, Epinephrine, Norepinephrine, Serotonin), Prognostic Nutritional Index, Glasgow Prognostic Score, Systemic Inflammatory Response Markers, and TNM Staging in a Cohort of Colorectal Neuroendocrine Tumor Patients.
    Cîmpeanu RC; Boldeanu MV; Ahrițculesei RV; Ciobanu AE; Cristescu AM; Forțofoiu D; Siloși I; Pirici DN; Cazacu SM; Boldeanu L; Vere CC
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer.
    Hou Y; Li X; Yang Y; Shi H; Wang S; Gao M
    Front Immunol; 2023; 14():1274431. PubMed ID: 38022654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Inflammatory Markers and Local Recurrence in Patients with Giant Cell Tumor of Bone: A Preliminary Result.
    Tsukamoto S; Mavrogenis AF; Alvarado RA; Traversari M; Akahane M; Honoki K; Tanaka Y; Donati DM; Errani C
    Curr Oncol; 2023 Jan; 30(1):1116-1131. PubMed ID: 36661734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]   [Full Text] [Related]  

  • 6. A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients.
    Ren L; Xu J; Li J; Xu T; Yang Y; Wang W; Ren Y; Gu S; Chen C; Wei Z; Zhuang J; Wang Z; Ji L; Cheng L; Wang W; Cheng Z; Ke Y; Yuan L; Liu P
    Clin Exp Med; 2023 Oct; 23(6):2583-2591. PubMed ID: 36639599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer.
    Florescu DN; Boldeanu MV; Șerban RE; Florescu LM; Serbanescu MS; Ionescu M; Streba L; Constantin C; Vere CC
    Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old.
    Su JY; Wang Y; Wu SS; Li WK; Wang CY; Ma JY; Qiu YT; Zhou MS; Wang Z; Li P; Liu CT; Wu J
    Carcinogenesis; 2023 Dec; 44(12):824-836. PubMed ID: 37713476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis.
    Russo E; Guizzardi M; Canali L; Gaino F; Costantino A; Mazziotti G; Lania A; Uccella S; Di Tommaso L; Ferreli F; Malvezzi L; Spriano G; Mercante G
    Rev Endocr Metab Disord; 2024 Apr; 25(2):449-450. PubMed ID: 37979073
    [No Abstract]   [Full Text] [Related]  

  • 10. Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients.
    Jakubowska K; Koda M; Grudzińska M; Kańczuga-Koda L; Famulski W
    World J Gastroenterol; 2020 Aug; 26(31):4639-4655. PubMed ID: 32884222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implication of systemic inflammatory markers in young patients with resectable colorectal cancer.
    Lee SY; Lee SI; Min BW; Oh SC
    Ann Surg Treat Res; 2021 Jan; 100(1):25-32. PubMed ID: 33457394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of the Neutrophil-to-Lymphocyte and Lymphocyte-to-Monocyte Ratio, in Patients with Rectal Cancer: A Retrospective Study of 1052 Patients.
    Fülöp ZZ; Gurzu S; Fülöp RL; Bara T; Tímár J; Drágus E; Jung I
    J Pers Med; 2020 Oct; 10(4):. PubMed ID: 33081102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative neutrophil-to-lymphocyte ratio as a predictive factor for survival in nonmetastatic colorectal cancer.
    Gülben K; Berberoğlu U; Öndeş B; Uyar O; Güler OC; Turanlı S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S189-S193. PubMed ID: 33380676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
    Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
    J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation Between the Glasgow Prognostic Score and the Serum Cytokine Profile in Taiwanese Patients with Colorectal Cancer.
    Yu YL; Fan CW; Tseng WK; Chang PH; Kuo HC; Pan YP; Yeh KY
    Int J Biol Markers; 2021 Jun; 36(2):40-49. PubMed ID: 34096371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer.
    Xiao Z; Wang X; Chen X; Zhou J; Zhu H; Zhang J; Deng W
    Front Oncol; 2023; 13():1064343. PubMed ID: 37064153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients.
    Yamamoto T; Kawada K; Obama K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of nutritional and inflammatory markers in patients with pancreatic cancer.
    Lu JN; Zhou LS; Zhang S; Li JX; Xu CJ
    World J Clin Oncol; 2024 Aug; 15(8):1021-1032. PubMed ID: 39193151
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.